Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.

Nitric oxide (NO), a mediator involved in penile erection, is synthesized by the nitric oxide synthase (NOS) family of enzymes. It has been shown that NOS activity decreases with age. To determine whether adenoviral-mediated overexpression of endothelial NOS (eNOS) could enhance erectile responses, we administered a recombinant adenovirus containing the eNOS gene (AdCMVeNOS) into the corpora cavernosum of the aged rat. Adenoviral expression of the beta-galactosidase reporter gene was observed in cavernosal tissue 1 day after intracavernosal administration of AdCMVbetagal; 1 day after administration of AdCMVeNOS, transgene expression was confirmed by immunoblot staining of eNOS protein, and cGMP levels were increased. The increase in cavernosal pressure in response to cavernosal nerve stimulation was enhanced in animals transfected with eNOS, and erectile responses to acetylcholine and zaprinast were enhanced at a time when the erectile response to the NO donor sodium 1-(N,N-diethylamino)diazen-1-ium-1,2-diolate was not altered. These results suggest that in vivo gene transfer of eNOS, alone or in combination with a type V phosphodiesterase inhibitor, may constitute a new therapeutic intervention for the treatment of erectile dysfunction.

[1]  L. Ortiz,et al.  Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses. , 1999, Circulation research.

[2]  P. C. Doherty,et al.  Induction of penile erection by intracavernosal and transurethral administration of novel nitric oxide donors in the cat. , 1999, The Journal of urology.

[3]  D. Heistad,et al.  Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[4]  A E Smith,et al.  Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. , 1998, Human gene therapy.

[5]  A. Melman,et al.  The application of gene therapy to the treatment of erectile dysfunction , 1998, International Journal of Impotence Research.

[6]  A. Argiolas,et al.  Role op central nitric oxide in the control of penile erection and yawning , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  E. Nabel,et al.  In vivo gene delivery to the pulmonary circulation in rats: transgene distribution and vascular inflammatory response. , 1997, American journal of respiratory cell and molecular biology.

[8]  T. Rajavashisth,et al.  Cloning of rat and human inducible penile nitric oxide synthase. Application for gene therapy of erectile dysfunction. , 1997, Biology of reproduction.

[9]  A. Argiolas,et al.  Dopamine Agonists Increase Nitric Oxide Production in the Paraventricular Nucleus of the Hypothalamus: Correlation with Penile Erection and Yawning , 1996, The European journal of neuroscience.

[10]  S. Snyder,et al.  Review of Impotence Literature , 1996, International Journal of Impotence Research.

[11]  J. Rajfer,et al.  Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. , 1995, Endocrinology.

[12]  A. Burnett,et al.  Nitric oxide control of lower genitourinary tract functions: a review. , 1995, Urology.

[13]  A. Burnett Role of nitric oxide in the physiology of erection. , 1995, Biology of reproduction.

[14]  K. Andersson,et al.  Physiology of penile erection. , 1995, Physiological reviews.

[15]  H A Feldman,et al.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.

[16]  K. Anderson Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. , 1993, Pharmacological reviews.

[17]  S. Snyder,et al.  Nitric oxide: a physiologic mediator of penile erection. , 1992, Science.

[18]  L. Ignarro,et al.  Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. , 1992, The Journal of urology.

[19]  L. Ignarro,et al.  Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission , 1992 .

[20]  L. Ignarro,et al.  Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. , 1990, Biochemical and biophysical research communications.